[P4–004]: THE COMBINATION OF CITALOPRAM AND RIVASTIGMINE IN THE TREATMENT OF MOOD DISORDER AND COGNITIVE IMPAIRMENT DUE TO CEREBROVASCULAR DISEASE: A CASE REPORT AND LITERATURE REVIEW. (1st July 2017)